Survival outcomes following autologous stem cell transplant with melphalan 140mg/m
2
versus 200mg/m
2
preparative regimens in patients with multiple myelo
Leukemia & Lymphoma | May 18, 2023 | Volume: 64 | Issue: 7 | Pages: 1315-1321
10.1080/10428194.2023.2213366
| PMID 37199099